CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −480 | $525.93 | $252K | 47,173 |
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −680 | $526.94 | $358K | 46,493 |
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $528.02 | $211K | 46,093 |
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $529.48 | $148K | 45,813 |
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −480 | $530.73 | $255K | 45,333 |
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,605 | $532.24 | $854K | 43,728 |
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,890 | $533.21 | $1.0M | 41,838 |
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −709 | $534.31 | $379K | 41,129 |
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −536 | $535.39 | $287K | 40,593 |
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $536.02 | $43K | 40,513 |
| 2026-03-24 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 78,500 | ||
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −200 | $518.28 | $104K | 28,676 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −640 | $519.30 | $332K | 28,036 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −875 | $520.62 | $456K | 27,161 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −905 | $521.47 | $472K | 26,256 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −200 | $522.36 | $104K | 26,056 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −440 | $524.20 | $231K | 25,616 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −320 | $525.37 | $168K | 25,296 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −520 | $526.57 | $274K | 24,776 |
Page 141 of 171 · 3,408 trades